益生菌预处理联合四联疗法治疗初治失败幽门螺杆菌感染的临床效果

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the curative effect of pretreatment with Probiotics combined with quadruple therapy in the remedial treatment of infection of Helicobacter pylori (Hp).Methods From June 2016 to June 2018, 104 patients with Hp positive initial failure in our hospital were selected and divided into experimental group (n=52) and control group (n=52) number according to the patient′s medical treatment sequence.The patients in the control group were treated with routine quadruple therapy (Rabeprazole+Amoxicillin+Clavulacillin Citrate+Potassium Bismuth Citrate),while the patients in the experimental group were treated with Bifidobacterium Tetracycline Tablets for two weeks and then the patients in the experimental group were treated with routine quadruple therapy.Two groups of patients were treated for 2 weeks, and eradication effect and adverse reactions of Hp eradication between the two groups were compared.The tolerance of the two groups was counted.Results The effective rates of eradication of Hp in the experimental group and the control group were 84.62% and 78.85%, respectively, there was no significant difference between the two groups (P＞0.05).The incidence of adverse reactions in the experimental group was 1.92%, which was lower than that of the control group (17.31%), the difference was statistically significant (P<0.05).The grade distribution of tolerance in the experimental group was lower than that in the control group, and the difference was statistically significant(P<0.05).Conclusion After the failure of the first treatment, the Hp infection was treated with Bifidobacterium Quadruple Live Bacteria Tablets for two weeks and then treated with conventional quadruple therapy for remedial treatment, although the eradication rate of Hp could not be improved exactly, it is helpful to reduce the adverse reactions and improve the tolerance of patients, which has certain clinical application value.

Key words： Probiotics pretreatment Quadruple therapy Helicobacter Pylori Infection Remedial treatment Helicobacter Pylori eradication

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHAN Yun-kai
	YI Jing
	DUAN Zhi-gang

Cite this article:

ZHAN Yun-kai,YI Jing,DUAN Zhi-gang. Clinical effect of Probiotics pretreatment combined with quadruple therapy in the treatment of failed Helicobacter pylori infection[J]. 中国当代医药, 2020, 27(3): 65-67.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I3/65

[1]	王巧敏，刘怀昌，李妙根.益生菌联合改良序贯疗法治疗初治失败幽门螺杆菌感染的疗效研究[J].临床内科杂志，2015，32（8）：550-552.
[2]	肖世元.益生菌联合四联疗法治疗老年人群幽门螺杆菌感染的疗效分析[J].实用医院临床杂志，2018，15（6）：126-128.
[3]	张健，李洪运.四联疗法根治幽门螺旋杆菌感染疗效分析[J].中国病原生物学杂志，2014，9（8）：747-749.
[4]	钱峰.益生菌联合四联疗法治疗青少年人群幽门螺旋杆菌感染的临床疗效观察[J].中国医药科学，2016，6（12）：40-42.
[5]	陈旭，雷蕾，邹建文.枯草杆菌联合四联疗法补救对老年幽门螺杆菌感染者的疗效[J].国际消化病杂志，2018，38（4）：258-261.
[6]	李淑红，刘华一，唐艳萍.香砂六君子汤联合四联疗法治疗幽门螺杆菌感染致脾胃虚弱型消化性溃疡48 例临床观察[J].中医杂志，2016，57（21）：1854-1857.
[7]	赵晨，沈琪乐，徐辉.微生态制剂联合四联疗法治疗老年人群幽门螺旋杆菌感染的疗效评价[J].实用临床医药杂志，2015，19（17）：116-118.
[8]	刘海燕，陈军贤，钟燕敏，等.四联疗法与序贯疗法联合益生菌治疗幽门螺杆菌感染的临床研究[J].中华医院感染学杂志，2014，24（8）：1950-1952.
[9]	谢代彬，王梅，贾雁平，等.消化性溃疡合并幽门螺杆菌感染患儿奥美拉唑四联疗法治疗效果分析[J].中华医院感染学杂志，2016，26（5）：1146-1148.
[10]	伍银桥，李军，李英男.益生菌联合四联疗法治疗老年人幽门螺杆菌感染的临床观察[J].中华老年多器官疾病杂志，2017，16（6）：418-422.
[11]	李桂水，杨敏京，边连朵，等.四联疗法联合口腔洁治对胃溃疡患者胃幽门螺杆菌根除的临床疗效观察[J].中国现代医学杂志，2016，26（5）：140-142.
[12]	郭俊芝，赵和平，党小红，等.含呋喃唑酮四联及四联联合益生菌补救治疗幽门螺杆菌感染的疗效分析[J].中国药物与临床，2016，16（10）：1477-1479.
[13]	朱新影，杜娟，赵文娟，等.两种益生菌联合铋剂四联疗法根除幽门螺杆菌疗效分析[J].中华医学杂志，2018，98（28）：2246.
[14]	钱小棋，陈玲玲，钟海兵.益生菌联合抗幽门螺杆菌治疗对消化性溃疡患者的疗效[J].中国微生态学杂志，2018，30（2）：566-567.
[15]	张冰，王艳玲，李炳庆，等.四联疗法联合益生菌治疗幽门螺杆菌疗效观察[J].河北医学，2017，23（4）：613-616.
[16]	袁丽，于泳，梅璐，等.益生菌联合四联疗法对幽门螺杆菌感染补救治疗的疗效分析[J].中国微生态学杂志，2017，29（8）：916-919.